Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: A systematic review and meta-analysis.

Lina Palaiodimou Maria-Ioanna Stefanou Aristeidis H KatsanosParaskevi C FragkouMarianna PapadopoulouChristos MoschovosIoannis MichopoulosPanagiotis KokotisChristos BakirtzisAndroniki NaskaTheodoros I VassilakopoulosElisabeth ChroniSotirios TsiodrasGeorgios K Tsivgoulis

Published in: European journal of neurology (2021)

GBSs prevalence was estimated at 15 cases per 100,000 SARS-CoV-2 infections. COVID-19 appears to be associated with an increased likelihood of GBSs and with demyelinating GBSs variants in particular.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
risk factors
copy number
gene expression
case report
metabolic syndrome
type diabetes
dna methylation
adipose tissue
insulin resistance